2.5. Statistical Analysis

MO Masahisa Ohtsuka
HL Hui Ling
CI Cristina Ivan
MP Martin Pichler
DM Daisuke Matsushita
MG Matthew Goblirsch
VS Verena Stiegelbauer
KS Kunitoshi Shigeyasu
XZ Xinna Zhang
MC Meng Chen
FV Fnu Vidhu
GB Geoffrey A. Bartholomeusz
YT Yuji Toiyama
MK Masato Kusunoki
YD Yuichiro Doki
MM Masaki Mori
SS Shumei Song
JG Jillian R. Gunther
SK Sunil Krishnan
OS Ondrej Slaby
AG Ajay Goel
JA Jaffer A. Ajani
MR Milan Radovich
GC George A. Calin
request Request a Protocol
ask Ask a question
Favorite

We analyzed the association of gene expression or other clinical parameters (sex, age, tumor location, tumor stage) with survival using a Cox proportional hazard model. In the multivariable regression model, only the factors that were statistically significant in univariable analyses were included. After determining the cut-off value that allows most significant split with log-rank test in the TCGA dataset, we used the same cut-off value to generate Kaplan-Meier plots for all cohorts. The Spearman's rank correlation was applied for the strength of association between tested genes. The differences between groups were analyzed using 2-way ANOVA analysis, t-test, or nonparametric test, with the GraphPad software. Graphics represent the mean ± standard deviation from at least two independent experiments repeated in triplicate, unless otherwise stated. Statistical significance was considered if P < 0.05.

Additional methods, including Cell Culture, RNA interference experiments, Proliferation Assay, Cell Scratch Assay, Cell-Cycle Assay, Click-iT EdU Assay, Reverse Transcription Quantitative RT-PCR Analysis, Western Blot, Plasmid and Virus Generation, and Northern Blot are available in Supplemental Experimental Procedures. Reagent, primer, and antibody information is available in Table S3–5.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A